Deze website maakt gebruik van cookies. We gebruiken cookies om instellingen te onthouden en je bezoek soepeler te laten verlopen. Daarnaast gebruiken we ook cookies voor de verbetering van de website en het verzamelen en analyseren van statistieken. Lees meer over cookies

Home
Marc van de Wetering

Marc van de Wetering

Senior Onderzoeker

Clevers groep

Marc is onderzoeker in de groep van Hans Clevers.

Phone -

Email m.l.vandewetering@prinsesmaximacentrum.nl

Unbiased transcription factor CRISPR screen identifies ZNF800 as master repressor of enteroendocrine differentiation
- okt. 2023
- Lin, Lin, et al
- Science
Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities
- mei 2023
- Irene, Paassen, et al
- Oncogene
Multi-dimensional profiling of hepatoblastomas and patient-derived tumor organoids uncovers tumor subpopulations with divergent WNT activation profiles and identifies pan-hepatoblastoma drug sensitivities
- jan. 2023
- Thomas, Kluiver, et al
- bioRxiv
Ewing Sarcoma Single-cell Transcriptome Analysis Reveals Functionally Impaired Antigen-presenting Cells
- jan. 2023
- Lindy L., Visser, et al
- Cancer Research Communications
Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes
- aug. 2022
- Michael T, Meister, et al
- EMBO molecular medicine

Bekijk alle publicaties

Marc van de Wetering

Publicaties

Unbiased transcription factor CRISPR screen identifies ZNF800 as master repressor of enteroendocrine differentiation

Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities

Multi-dimensional profiling of hepatoblastomas and patient-derived tumor organoids uncovers tumor subpopulations with divergent WNT activation profiles and identifies pan-hepatoblastoma drug sensitivities

Ewing Sarcoma Single-cell Transcriptome Analysis Reveals Functionally Impaired Antigen-presenting Cells

Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes